AAAAAA

   
Results: 1-12 |
Results: 12
TREATMENT OF THRUSH WITH ITRACONAZOLE SOLUTION - EVIDENCE FOR TOPICALEFFECT
Authors: MASCARENAS CA HARDIN TC PENNICK GJ RINALDI MG GRAYBILL JR
Citation: Ca. Mascarenas et al., TREATMENT OF THRUSH WITH ITRACONAZOLE SOLUTION - EVIDENCE FOR TOPICALEFFECT, Clinical infectious diseases, 26(5), 1998, pp. 1242-1243
VANCOMYCIN-RESISTANT ENTEROCOCCI OSTEOMYELITIS IN THE FOOT - A CASE-REPORT
Authors: REYZELMAN AM VANGILS CC HARDIN TC VAYSER DJ HARKLESS LB
Citation: Am. Reyzelman et al., VANCOMYCIN-RESISTANT ENTEROCOCCI OSTEOMYELITIS IN THE FOOT - A CASE-REPORT, Journal of the American Podiatric Medical Association, 87(9), 1997, pp. 434-437
ADDED QUALIFICATIONS FOR PHARMACY SPECIALISTS - ANOTHER PERSPECTIVE
Authors: BOSSO JA HARDIN TC
Citation: Ja. Bosso et Tc. Hardin, ADDED QUALIFICATIONS FOR PHARMACY SPECIALISTS - ANOTHER PERSPECTIVE, The Annals of pharmacotherapy, 31(12), 1997, pp. 1535-1536
AMPHOTERICIN-B ENZYME-LINKED IMMUNOASSAY FOR CLINICAL USE - COMPARISON WITH BIOASSAY AND HPLC
Authors: CLEARY JD CHAPMAN SW HARDIN TC RINALDI MG SPENCER JL DENG J PENNICK GJ LOBB CJ
Citation: Jd. Cleary et al., AMPHOTERICIN-B ENZYME-LINKED IMMUNOASSAY FOR CLINICAL USE - COMPARISON WITH BIOASSAY AND HPLC, The Annals of pharmacotherapy, 31(1), 1997, pp. 39-44
KEY ISSUES CONCERNING FUNGISTATIC VERSUS FUNGICIDAL DRUGS
Authors: GRAYBILL JR BURGESS DS HARDIN TC
Citation: Jr. Graybill et al., KEY ISSUES CONCERNING FUNGISTATIC VERSUS FUNGICIDAL DRUGS, European journal of clinical microbiology & infectious diseases, 16(1), 1997, pp. 42-50
THERAPEUTIC DRUG-MONITORING OF SYSTEMIC ANTIFUNGAL THERAPY
Authors: SUMMERS KK HARDIN TC GORE SJ GRAYBILL JR
Citation: Kk. Summers et al., THERAPEUTIC DRUG-MONITORING OF SYSTEMIC ANTIFUNGAL THERAPY, Journal of antimicrobial chemotherapy, 40(6), 1997, pp. 753-764
DISCREPANCY BETWEEN IN-VITRO AND IN-VIVO ANTIFUNGAL ACTIVITY OF ALBENDAZOLE
Authors: HARDIN TC NAJVAR LK RIZZO J FOTHERGILL AW RINALDI MG GRAYBILL JR
Citation: Tc. Hardin et al., DISCREPANCY BETWEEN IN-VITRO AND IN-VIVO ANTIFUNGAL ACTIVITY OF ALBENDAZOLE, Journal of medical and veterinary mycology, 35(3), 1997, pp. 153-158
CRITICAL PATHWAYS - THE TIME IS HERE FOR PHARMACIST INVOLVEMENT
Authors: ZAROWITZ BJ NAPPI J DUKES GE CARTER BL BOUCHER BA BUSSEY HI HAK LJ HARDIN TC LAKE KD OCONNELL MB WELLS BG ELENBAAS RM KIRK JK MICHAEL KA MARKOWSKY SJ RESTINO MR
Citation: Bj. Zarowitz et al., CRITICAL PATHWAYS - THE TIME IS HERE FOR PHARMACIST INVOLVEMENT, Pharmacotherapy, 16(4), 1996, pp. 723-733
CEFEPIME
Authors: HARDIN TC JENNINGS TS
Citation: Tc. Hardin et Ts. Jennings, CEFEPIME, Pharmacotherapy, 14(6), 1994, pp. 657-668
COMPARISON OF AMPICILLIN-SULBACTAM AND TICARCILLIN-CLAVULANIC ACID INPATIENTS WITH CHRONIC-RENAL-FAILURE - EFFECTS OF DIFFERENTIAL PHARMACOKINETICS ON SERUM BACTERICIDAL ACTIVITY
Authors: HARDIN TC BUTLER SC ROSS S WAKEFORD JH JORGENSEN JH
Citation: Tc. Hardin et al., COMPARISON OF AMPICILLIN-SULBACTAM AND TICARCILLIN-CLAVULANIC ACID INPATIENTS WITH CHRONIC-RENAL-FAILURE - EFFECTS OF DIFFERENTIAL PHARMACOKINETICS ON SERUM BACTERICIDAL ACTIVITY, Pharmacotherapy, 14(2), 1994, pp. 147-152
TREATMENT OF ASPERGILLOSIS WITH ITRACONAZOLE
Authors: JENNINGS TS HARDIN TC
Citation: Ts. Jennings et Tc. Hardin, TREATMENT OF ASPERGILLOSIS WITH ITRACONAZOLE, The Annals of pharmacotherapy, 27(10), 1993, pp. 1206-1211
NUTRITIONAL PARAMETERS OBSERVED DURING 28-DAY INFUSION OF RECOMBINANTHUMAN TUMOR-NECROSIS-FACTOR-ALPHA
Authors: HARDIN TC KOELLER JM KUHN JG ROODMAN D VONHOFF DD
Citation: Tc. Hardin et al., NUTRITIONAL PARAMETERS OBSERVED DURING 28-DAY INFUSION OF RECOMBINANTHUMAN TUMOR-NECROSIS-FACTOR-ALPHA, JPEN. Journal of parenteral and enteral nutrition, 17(6), 1993, pp. 541-545
Risultati: 1-12 |